SCHEMBL7319852

SCHEMBL7319852

COc1c(O)c(O)cc2c(CCC(=O)O)c(O)nc(C)c12

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.37
KDM4E B2RXH2 5/20 0.37
ALDH1A1 P00352 5/20 0.37
HSD17B10 Q99714 5/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
POLB P06746 2/20 0.36
MAPT P10636 3/20 0.36
TP53 P04637 2/20 0.36
IMPDH2 P12268 2/20 0.36
P2RX3 P56373 4/20 0.34
MEN1 O00255 2/20 0.34
CYP3A4 P08684 2/20 0.34
PKM P14618 2/20 0.34
ALOX12 P18054 2/20 0.34
RECQL P46063 2/20 0.34
BLM P54132 2/20 0.34
KMT2A Q03164 2/20 0.34
GPR17 Q13304 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7316886 0.77 HSD17B10 (0.40) HPGDKDM4EALDH1A1HSD17B10SMN1; SMN2
SCHEMBL7317446 0.76 TP53 (0.44) HPGDKDM4EALDH1A1HSD17B10SMN1; SMN2
SCHEMBL7315407 0.75 PDE3B (0.46) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL7319846 0.74 AKR1B1 (0.34) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL15354651 0.65 POLB (0.45) HPGDKDM4EALDH1A1HSD17B10POLB
SCHEMBL7305966 0.64 PDE3B (0.57) HPGDKDM4EALDH1A1POLBMEN1
SCHEMBL9506843 0.64 NPSR1 (0.47) HPGDKDM4EALDH1A1HSD17B10P2RX3
SCHEMBL21317651 0.63 POLB (0.58) ALDH1A1POLB
SCHEMBL7320031 0.62 POLB (0.46) ALDH1A1SMN1; SMN2POLBMAPTIMPDH2
SCHEMBL3669296 0.61 NPSR1 (0.52) ALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4822800-A Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-04-18 US disclosed